Who Owns Boundless Bio Stock?
NASDAQ: BOLDHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 8, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 67.26%
- Held by insiders
- 12.09%
- Institutional holders
- 44
- Institutions 67.3%
- Insiders 12.1%
- Public and other 20.6%
Who owns Boundless Bio stock?
Institutional investors own about 67.3% of Boundless Bio's shares, spread across 44 institutions that file 13F reports. That level of institutional ownership is moderate. Insiders, including executives, directors and large founding shareholders, hold 12.09% of BOLD.
The largest institutional holders are Arch Venture Management, Llc (11.84%), FMR, LLC (11.35%) and Tang Capital Management, LLC (11.25%). Together, the top 10 institutions control 58.1% of shares outstanding. In their latest filings, 7 of the top 10 institutions increased their BOLD positions and 1 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of BOLD
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Arch Venture Management, Llc | 2.69M | 11.84% | +100.0% |
| FMR, LLC | 2.58M | 11.35% | -4.2% |
| Tang Capital Management, LLC | 2.56M | 11.25% | +100.0% |
| Adar1 Capital Management, LLC | 1.97M | 8.65% | +100.0% |
| Cormorant Asset Management, LP | 1.00M | 4.40% | +100.0% |
| Vanguard Capital Management LLC | 614.92K | 2.70% | +3.0% |
| Wellington Management Group, LLP | 556.23K | 2.45% | 0.0% |
| Millennium Management Llc | 478.64K | 2.10% | +379.2% |
| Renaissance Technologies, LLC | 471.57K | 2.07% | +18.2% |
| Alyeska Investment Group, L.p. | 300.00K | 1.32% | 0.0% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of BOLD
| Fund | Shares | % Held |
|---|---|---|
| Fidelity Mt. Vernon Street Trust-Fidelity Growth Company Fund | 899.16K | 3.95% |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 445.18K | 1.96% |
| Fidelity Mt. Vernon Street Trust-Fidelity Growth Company K6 Fund | 227.61K | 1.00% |
| Fidelity Mt. Vernon Street Trust-Fidelity Series Growth Company Fund | 193.12K | 0.85% |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 152.01K | 0.67% |
| Bridgeway Funds, Inc.-Ultra-Small Company Fund | 77.50K | 0.34% |
| Fidelity Concord Street Trust-Fidelity Extended Market Index Fund | 68.00K | 0.30% |
| iShares Trust-iShares Micro-Cap ETF | 58.46K | 0.26% |
| Fidelity Concord Street Trust-Fidelity Series Total Market Index Fund | 18.98K | 0.08% |
| VANGUARD VALLEY FORGE FUNDS-Vanguard Balanced Index Fund | 17.73K | 0.08% |
Frequently asked questions
Who is the largest shareholder of Boundless Bio?
Arch Venture Management, Llc is the largest institutional shareholder of BOLD, owning 11.84% of shares outstanding (2.69M shares) as of its latest 13F filing.
What percentage of Boundless Bio is owned by institutions?
Institutions own about 67.3% of BOLD shares and 76.5% of the public float.
How much of Boundless Bio do insiders own?
Insiders, such as officers and directors, own about 12.09% of BOLD shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.